HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

Affordable Care Act Marketplace Prices Fall Amid Increasing Competition

Average premiums for insurance plans in the Affordable Care Act marketplaces have dropped by 1.8% this year, marking the third consecutive year of price cuts. This three-year trend has followed an influx of new insurers entering the marketplaces formed by the Obama administration's flagship […]

more info 04/13/2022View Related Articles
Bookmark and Share

Regional Variations in Hospital Pricing Represent Potential Policy Target

The RAND Corporation recently published a report finding that, although hospitals’ commercial payer prices didn’t vary widely from Medicare prices, broad price variations existed between individual regions. These price differences, the report pointed out, are potential targets for healthcare pricing […]

more info 04/05/2022View Related Articles
Bookmark and Share

ICER Will Develop California State Unsupported Price Reports

The California Health Care Foundation (CHCF) has awarded The Institute for Clinical and Economic Review (ICER) a new grant to develop 2 California-specific unsupported price increase reports. In addition, the grant will support the development of a policymaker guide to use comparative effectiveness […]

more info 03/03/2022View Related Articles
Bookmark and Share

Study: High Prices May Not Translate to Better Care

The old adage “you get what you pay for” doesn’t neccesarily apply to healthcare, according to a recent study published in the National Bureau of Economic Research. The study examined employer sponsored insurance claims data from the Health Care Cost Initiative (HCCI) spanning from June 2007 to […]

more info 03/03/2022View Related Articles
Bookmark and Share

Cost-Sharing has Unforeseen Consequences for Patients and Payers

Cost-sharing measures like co-pays, deductibles, and co-insurance are ostensibly intended to help reduce payer costs and have patients take ownership of their care and make responsible treatment decisions. However, this information is not well-conveyed to patients and often results in patients not […]

more info 02/01/2022View Related Articles
Bookmark and Share

Drug Rebate Safe Harbor Protections Removed but Loopholes Still Remain

The Department of Health and Human Services (DHS) has nixed the “Safe Harbor” protections for pharma rebates to PBMs, according to Dr. Eric Bricker. Dr. Bricker explains that rebates are essentially a form of kickbacks, and therefore aren’t immune from the “Safe Harbor” laws. Now, rebates must be […]

more info 01/28/2022View Related Articles
Bookmark and Share

Congress Pursuing Price Setting Measures that May Not Benefit Patients

In a new PhRMA article, Nicole Longo argues that Congress is starting off the year on a wrong foot with price-setting measures included in the Build Back Better Act (BBBA). She argues that the policies, if passed, would disincentivize research on medications after they’re approved, discourage […]

more info 01/27/2022View Related Articles
Bookmark and Share

Michigan Attorney General Seeks Investigation Regarding Eli Lilly’s Exorbitant Insulin Prices

The Michigan Attorney General has asked the courts to approve a formal investigation into Eli Lilly’s excessive insulin prices. The state points out that the prices are having an inordinate impact on consumers in their state, with the average out-of-pocket price approaching $100. While Eli Lilly’s […]

more info 01/27/2022View Related Articles
Bookmark and Share

States Can Help Lower Medicine Costs for Patients

Medicine costs for patients have spiked in the past few years, especially for patients with deductibles who often pay the list price for drugs their insurers are compensated for. In a recent PhRMA article, Scott LaGanga recommends several methods by which state legislatures can reduce medicine costs […]

more info 01/27/2022View Related Articles
Bookmark and Share

ICER Releases Draft Report on Plinabulin and Trilaciclib for Chemo-induced Neutropenia

The Institute for Clinical and Economic Review (ICER) has released its draft evidence report for the novel drugs plinabulin (BeyondSpring Pharmaceuticals) and trilaciclib (Cosela™, G1 Therapeutics). The report assessed the comparative clinical effectiveness and value of the two drugs that are […]

more info 01/26/2022View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 39
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • SQL Developer
  • Senior Research Consultant - Modelling and Meta Analysis
  • Research Consultant - Evidence Synthesis & Economic Modelling
  • Associate Director – Modelling & Meta-Analysis
  • Director, Real World Evidence
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists